메뉴 건너뛰기
Lancet
Volumn 351, Issue 9106, 1998, Pages 851-852
Adverse reactions to levodopa: Drug toxicity or progression of disease?
Author keywords

[No Author keywords available]
Indexed keywords

BENSERAZIDE; CARBIDOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE INHIBITOR;
EID: 0032554497     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70285-3     Document Type: Note
Times cited : (40)
References (9)
  • 1
    • 0023261984 scopus 로고
    • Does long term aggravation of Parkinson's disease result from non-dopaminergic lesions?
    • AM Bonnet Y Loria MH Saint-Hilaire F Lhermitte Y Agid Does long term aggravation of Parkinson's disease result from non-dopaminergic lesions? Neurology 37 1987 1539 1542
    • (1987) Neurology , vol.37 , pp. 1539-1542
    • Bonnet, AM1    Loria, Y2    Saint-Hilaire, MH3    Lhermitte, F4    Agid, Y5
  • 2
    • 0029775677 scopus 로고    scopus 로고
    • Is Ievodopa toxic?
    • S Fahn Is Ievodopa toxic? Neurology 47 suppl 3 1996 S184 S195
    • (1996) Neurology , vol.47 , Issue.suppl 3 , pp. S184-S195
    • Fahn, S1
  • 3
    • 0023226021 scopus 로고
    • Multi-center study of Parkinson's mortality with early versus late dopa treatment
    • SG Diamond CH Markham MM Hoehn FH McDowell MD Muenter Multi-center study of Parkinson's mortality with early versus late dopa treatment Ann Neurol 22 1987 8 12
    • (1987) Ann Neurol , vol.22 , pp. 8-12
    • Diamond, SG1    Markham, CH2    Hoehn, MM3    McDowell, FH4    Muenter, MD5
  • 4
    • 0002469587 scopus 로고
    • Autopsy findings in parkinsonism following treatment with levodopa
    • MD Yahr A Wolf JL Antunes K Miyoshi P Duffy Autopsy findings in parkinsonism following treatment with levodopa Neurology 22 suppl 1972 56 71
    • (1972) Neurology , vol.22 , Issue.suppl , pp. 56-71
    • Yahr, MD1    Wolf, A2    Antunes, JL3    Miyoshi, K4    Duffy, P5
  • 5
    • 0000154106 scopus 로고
    • Improved dopaminergic therapy of Parkinson's disease
    • MM Mouradian TN Chase Improved dopaminergic therapy of Parkinson's disease CD Marsden S Fahn Movement disorders 3 1994 Butterworth-Heinemann Ltd Oxford 181 199
    • (1994) , pp. 181-199
    • Mouradian, MM1    Chase, TN2
  • 6
    • 0030901296 scopus 로고    scopus 로고
    • Absence of neurotoxicity of chronic L-DOPA treatment in 6-hydroxydopamine lesioned rats
    • G Dziewczapolski G Murer Y Agid O Gershanik R Raisman-Vozari Absence of neurotoxicity of chronic L-DOPA treatment in 6-hydroxydopamine lesioned rats Neuronport 8 1997 975 979
    • (1997) Neuronport , vol.8 , pp. 975-979
    • Dziewczapolski, G1    Murer, G2    Agid, Y3    Gershanik, O4    Raisman-Vozari, R5
  • 7
    • 0029915162 scopus 로고    scopus 로고
    • Glia conditioned medium protects fetal rat midbrain neurones in culture from L-DOPA toxicity
    • MA Mena LJ Casajeros A Carazo CL Paino JG de Yebenes Glia conditioned medium protects fetal rat midbrain neurones in culture from L-DOPA toxicity Neuroreport 7 1996 441 445
    • (1996) Neuroreport , vol.7 , pp. 441-445
    • Mena, MA1    Casajeros, LJ2    Carazo, A3    Paino, CL4    de Yebenes, JG5
  • 8
    • 0030059868 scopus 로고    scopus 로고
    • L-DOPA up-regulates glutathione and protects mesencephalic culturs oxidative stress
    • SK Han C Mytilineou F Cohen L-DOPA up-regulates glutathione and protects mesencephalic culturs oxidative stress J Neurochem 66 1996 501 510
    • (1996) J Neurochem , vol.66 , pp. 501-510
    • Han, SK1    Mytilineou, C2    Cohen, F3
  • 9
    • 0002789021 scopus 로고
    • On-off phenomena in Parkinson's disease
    • CD Marsden On-off phenomena in Parkinson's disease UK Rinne S Klinger G Stamm Current progress, problems and management 1980 North Holland Biomedical Press Amsterdam 241 254
    • (1980) , pp. 241-254
    • Marsden, CD1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.